Avenzo

formerly Avenzo Therapeutics

Developing the next generation of oncology therapies for patients

San Diego, United States · Founded 2022 · $832.0M raised

Employees
1–10
Founded
2022
Business Model
B2B
Total Funding
$832.0M
Last Round
$60.0M Series BSep 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Avenzo Therapeutics is a clinical-stage biopharmaceutical company focused on developing next-generation small-molecule and antibody-drug conjugate (ADC) therapies for oncology. Founded in 2022 by veterans of Turning Point Therapeutics (acquired by Bristol Myers Squibb for $4.1B in 2022), the San Diego-based company targets cancers with high unmet medical needs. The company has raised over $60M in Series B financing with backing from OrbiMed, Foresite Capital, SR One, NEA, Lilly Asia Ventures, Sands Capital, and others.

Summary

Avenzo is a Biotech company based in San Diego, United States, founded in 2022. It has raised $832.0M in total across 4 rounds, most recently a $60.0M Series B round in Sep 2025. Investors include Deep Track Capital, Sofinnova Investments and Sands Capital.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BSep 2025
$60.0M

Sign up to see all 4 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Bicycle TherapeuticsIPO

Novel bicyclic peptides and drug conjugates for cancer

Cambridge, United States201–500Biotech, Oncology
Private EquityTotal funding$607.0MJan 2024
Arcus BiosciencesIPO

Clinical-stage biopharmaceutical company founded in 2015 developing best-in-class cancer therapeu...

Hayward, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$544.0MJan 2024
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Avenzo on Indexed.vc
<a href="https://indexed.vc/companies/avenzo"><img src="https://indexed.vc/api/badge/company/avenzo" alt="Avenzo on Indexed.vc" width="260" height="76" /></a>